Nanobiotix S.A.
NBTX
$51.50
-$3.57-6.48%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -0.43% | -80.52% | |||
| Total Other Revenue | -0.44% | -25.30% | |||
| Total Revenue | -0.43% | -76.97% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -0.43% | -76.97% | |||
| SG&A Expenses | -0.43% | -17.31% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.43% | -29.58% | |||
| Operating Income | 0.43% | -1,578.40% | |||
| Income Before Tax | 0.43% | -255.97% | |||
| Income Tax Expenses | 5.56% | -152.94% | |||
| Earnings from Continuing Operations | 0.43% | -255.51% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.43% | -255.51% | |||
| EBIT | 0.43% | -1,578.40% | |||
| EBITDA | 0.43% | -1,193.39% | |||
| EPS Basic | 0.44% | -249.69% | |||
| Normalized Basic EPS | 0.39% | -170.98% | |||
| EPS Diluted | 0.44% | -251.86% | |||
| Normalized Diluted EPS | 0.39% | -170.98% | |||
| Average Basic Shares Outstanding | 0.00% | 1.69% | |||
| Average Diluted Shares Outstanding | 0.00% | 1.69% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||